Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age
Open Access
- 13 January 2010
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 16 (6) , 792-800
- https://doi.org/10.1016/j.bbmt.2009.12.537
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantationProceedings of the National Academy of Sciences, 2009
- Optimal management of adults with ALLBritish Journal of Haematology, 2009
- Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study GroupJournal of Clinical Oncology, 2005
- Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old questionLeukemia, 2005
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageBlood, 2005
- Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningLeukemia, 2004
- Trends in leukemia incidence and survival in the United States (1973–1998)Cancer, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988